Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Announces Executive Management Promotions Jun 02, 2016 Nektar Therapeutics and Daiichi Sankyo Europe GmbH Sign European Licensing Agreement for ONZEALD™ (etirinotecan pegol), an Investigational Drug Candidate Being Developed to Treat Patients with Advanced Breast Cancer and Brain Metastases Jun 01, 2016 Nektar Therapeutics Reports Financial Results for the First Quarter of 2016 May 03, 2016 Nektar to Announce Financial Results for the First Quarter 2016 on Tuesday, May 3, 2016, After Close of U.S.-Based Financial Markets Apr 28, 2016 Preclinical Data Presented at AACR Demonstrate that Combining NKTR-214 with Checkpoint Blockade is Superior to Dual Checkpoint Inhibition in Increasing Clonality of the T Cell Receptor (TCR) Repertoire and T Cell Tumor Infiltration Apr 18, 2016 Baxalta Expands Global Reach of ADYNOVATE for Hemophilia A Patients with Approval in Japan Apr 04, 2016 Nektar Therapeutics to Present at Cowen and Company's 36th Annual Health Care Conference in Boston, MA Mar 03, 2016 Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results Mar 01, 2016 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2015 on Tuesday, March 1, 2016, After Close of U.S.-Based Financial Markets Feb 26, 2016 Baxalta Announces Submission of Supplemental BLAs to Expand Use of ADYNOVATE to Pediatric Patients and Surgical Settings Feb 25, 2016 Pagination First page « first Previous page ‹ previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page next › Last page last »